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Abstract
Background:  The estimation of health impacts involves often uncertain input variables and
assumptions which have to be incorporated into the model structure. These uncertainties may
have significant effects on the results obtained with model, and, thus, on decision making. Fine
particles (PM2.5) are believed to cause major health impacts, and, consequently, uncertainties in
their health impact assessment have clear relevance to policy-making. We studied the effects of
various uncertain input variables by building a life-table model for fine particles.
Methods: Life-expectancy of the Helsinki metropolitan area population and the change in life-
expectancy due to fine particle exposures were predicted using a life-table model. A number of
parameter and model uncertainties were estimated. Sensitivity analysis for input variables was
performed by calculating rank-order correlations between input and output variables. The studied
model uncertainties were (i) plausibility of mortality outcomes and (ii) lag, and parameter
uncertainties (iii) exposure-response coefficients for different mortality outcomes, and (iv)
exposure estimates for different age groups. The monetary value of the years-of-life-lost and the
relative importance of the uncertainties related to monetary valuation were predicted to compare
the relative importance of the monetary valuation on the health effect uncertainties.
Results: The magnitude of the health effects costs depended mostly on discount rate, exposure-
response coefficient, and plausibility of the cardiopulmonary mortality. Other mortality outcomes
(lung cancer, other non-accidental and infant mortality) and lag had only minor impact on the
output. The results highlight the importance of the uncertainties associated with cardiopulmonary
mortality in the fine particle impact assessment when compared with other uncertainties.
Conclusion: When estimating life-expectancy, the estimates used for cardiopulmonary exposure-
response coefficient, discount rate, and plausibility require careful assessment, while complicated
lag estimates can be omitted without this having any major effect on the results.
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Background
The estimation of health effects of environmental stres-
sors always involves uncertainty. The input variables
(data) or the mathematical formulation of the model con-
tain uncertainty, and some information may be missing.
The sources of uncertainty can be categorized into param-
eter and model uncertainties [e.g. [1,2]]. Depending on
the situation, uncertainties may have large impacts on
model results and, thus, lead to a situation where uncer-
tainties hamper decision-making.
Fine particles (PM2.5) have been shown to damage the
health. The Clean Air for Europe (CAFE) program, funded
by the European Commission, claimed that fine particles
cause over 300000 premature deaths annually in Europe
and lower the average life-expectancy by 8.6 months [3].
In this respect, air pollution by fine particles is one of the
most important environmental health problems in
Europe.
The health effects of PM2.5 have been assessed using both
additional mortality and life-expectancy methods. The
additional mortality (estimating the number of premature
deaths) method has been used in a number of health risk
studies to measure changes in annual or daily mortality
[e.g. [4,5]]. Another approach, estimation of the life-
expectancy of a population by using a life-table method
[6], has also been used [e.g. [7-9]]. The advantage of life-
expectancy predictions is that the method predicts cor-
rectly the change in the population age structure. The
practical downside is that life-expectancy method requires
more laborious intensive models and more input varia-
bles.
The sensitivity of life-table models to uncertainties in
some input variables has been investigated in several stud-
ies. Although several models with different assumptions
have been created, there is no comprehensive sensitivity
analysis of all key assumptions and input variables in the
PM2.5 life-table models. Brunekreef [7] concluded that the
life-expectancy predictions are sensitive to extrapolation
of cohort studies results to the older age groups.
Nevalainen and Pekkanen [9] compared the loss of life-
expectancy due to lung cancer and cardiopulmonary mor-
tality using two different cohort study estimates [10,11].
Their results indicated that the predictions of the health
effects differ largely between the different causes and
between the estimates obtained from different studies.
Rabl claimed that the infant mortality had only a minor
effect on life-expectancy [12]. Uncertainty due to lag has
been noted to be small when compared with the uncer-
tainties encountered in epidemiological studies [13]. In
the present article, lag was defined as the time elapsing
between a change in exposure and the ensuing change in
the hazard rate. Discounting has been used to express
future benefits as present values. It has had varying effects
on the results, depending on the outcome being assessed
[13,14]. The uncertainty analysis, which was done in
CAFE program, contained also input variables from the
life-table model (e.g. concentration-response functions,
monetary valuation) [15].
In this article, we compare uncertainties of fine particle
life-table model attributable to different sources: different
health outcomes, lag of the health effects, and change in
the exposure. In addition, we used the monetary value of
years-of-life-lost and the relative importance of the uncer-
tainties related to monetary valuation (discount and valu-
ation of a life-year-lost). The model was implemented for
the year 2002 Helsinki metropolitan area population. The
aims of this study were (i) to quantify the effect of the
uncertainty on life-table model results and (ii) to compare
the relative importance of the different input variables
(parameter uncertainty) and model assumptions (model
uncertainty).
Methods
Overview of the model
The effect of uncertainty was studied by conducting a
comprehensive sensitivity analysis of a life-table model.
Both parameter and model uncertainties were propagated
through the model by Monte Carlo simulation. The
model uncertainty was described with binary variables
(Bernoulli distribution), choosing between two alterna-
tive model branches (exception discount rate). Parameter
uncertainty was described by using continuous distribu-
tions. The effects of parameter and model uncertainties on
model results were studied using sensitivity analysis. The
sensitivity analysis was done by calculating absolute rank-
order correlations between the input variables and the
model results. All the studied input variables are pre-
sented in table 1.
Life-expectancy (LE) and monetary value of lost life years
were predicted. The LE was predicted by defining the
change in the background hazard rate caused by local-traf-
fic-related primary fine particles. The effects of fine parti-
cles were predicted for both infants and adults. The time
difference between an exposure and the consequent
health effects (lag) was included in the model. The relative
risk and lag estimates are described below. The monetary
value of life-year-lost was predicted by calculating a value
for a life year and discounting the future benefits and
costs. The model was implemented using Analytica ™ ver-
sion 3.1.1. (Lumina Decision Systems, Inc., CA) Monte
Carlo simulation program and run with 5 000 iterations.
Exposure scenarios sub-model (∆Ek)
Exposure scenarios were based on the local traffic-related
exposure variables that were defined within the projectEnvironmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
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Table 1: Input variables included in the sensitivity analysis.
Variable Type of uncertainty Distribution Parameters Explanation and references
Exposure-response 
coefficient for 
cardiopulmonary mortality, 
adults (RR)
Parameter uncertainty Mixeda 1.12 (1.04;1.27) Relative increase of mortality 
per 10 µgm-3 increase of 
PM2.5 exposure. Values were 
drawn with equal probability 
from the two distributions 
reported in the references 
Dockery et al. 1993 [10] and 
Pope et al. 2002 (table 3, 
average between 1979 and 
1999-200 results) [25].
Exposure-response 
coefficient for lung cancer 
mortality, adults (RR)
Parameter uncertainty Mixed 1.15 (0.94;1.40)
Exposure-response 
coefficient for all other non-
accidental mortality, adults 
(RR)
Parameter uncertainty Mixed 1.01 (0.91;1.09)
Plausibility, cardiopulmonary 
mortality
Model uncertainty Bernoullib P = 0.7 yes, P = 0.3 no AJc. Plausibility = "Is the 
observed effect due to true 
causal connection."
Plausibility, lung cancer 
mortality
Model uncertainty Bernoulli P = 0.9 yes, P = 0.1 no
Plausibility, other mortality Model uncertainty Bernoulli P = 0.1 yes, P = 0.9 no
Exposure-response 
coefficient for non-accidental 
mortality, infants (RR)
Parameter uncertainty Normald 1.04; 0.013 Relative increase of infant 
mortality (less than one year 
old infants) per 10 µgm-3 
increase of PM2.5 exposure. 
Reference Woodruff et al. 
1997 [30].
Plausibility, non-accidental 
mortality, infant
Model uncertainty Bernoulli P = 0.6 yes, P = 0.4 no AJ. Plausibility = "Is the 
observed effect due to true 
causal connection."
Lag vs. zero-lag Model uncertainty Bernoulli P = 0.5 yes, P = 0.5 no AJ. Lag = the time difference 
between the exposure and 
the causal health effect. See 
The lag sub-model chapter 
for details.
Exposure (µgm-3), infants 
(2002) (∆E)
Parameter uncertainty Log-normale 0.31; 3.27 The exposure of study 
population for local traffic 
related primary fine particles 
(0–6, 7–59 and 59–110 years 
for infants, adults and elderly, 
respectively). The exposure 
model [19–21] was based on 
EXPOLIS-Helsinki study [22–
24]. See Exposure scenarios 
sub-model chapter for 
details.
Exposure (µgm-3), adults 
(2002) (∆E)
Parameter uncertainty Log-normal 0.56; 2.81
Exposure (µgm-3), elderly 
(2002) (∆E)
Parameter uncertainty Log-normal 0.55; 3.08
Exposure (µgm-3), infants 
(2025) (∆E)
Parameter uncertainty Log-normal 0.14; 3.56
Exposure (µgm-3), adults 
(2025) (∆E)
Parameter uncertainty Log-normal 0.21; 2.94
Exposure (µgm-3), elderly 
(2025) (∆E)
Parameter uncertainty Log-normal 0.2; 3.24
Valuation of a life-year-lost Parameter uncertainty Uniformf 52000; 120000 Min and max from CAFE 
study [39]. See text for 
details.
Discount Model uncertainty Uniform 0.02; 0.06 Min and max from CAFE 
study [39]. See text for 
details.
Blank - Uniform 0.0; 1.0 Blank = internal standard of 
the model. Not related to 
the model results.
a Mixed: Combination of two normally distributed variables (mean and 90% confidence intervals).
b Bernoulli (binomial) binary probability distribution with probabilities (P, 1-P)
c AJ = Author judgment.
d Parameters for normal distribution (mean; standard deviation)
e Parameters for log-normal distribution (median; geometric standard deviation)
f Parameters for uniform distribution (min; max)Environmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
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Health Effects caused by Urban Air Pollution for the Transport
System Plan Scenarios in Helsinki Area (HEAT). The HEAT
project evaluated traffic flows, air pollution emissions
from traffic, resulting ambient air concentrations and
exposures, and health effects in the Helsinki metropolitan
area. The evaluations were done for two years, 2002 (cur-
rent) and 2025 (the target year of the current transport
system plan of this area). The traffic volumes for 2025
were assessed by combining Helsinki metropolitan area
land use scenarios with a traffic demand model prepared
by the Helsinki Metropolitan Area Council (YTV). The
spatial distribution and the amount of key air pollution
emissions, including fine particles, were predicted from
the traffic flow estimations.
The hourly fine particle concentrations from primary traf-
fic emissions over the Helsinki metropolitan area were
computed by Finnish Meteorological Institute [16] within
spatial resolution ranging from 10 to 500 meters. Ambi-
ent concentrations from local traffic were sampled for res-
idential and occupational locations using a stratified
random sampling scheme and small-area planning dis-
tricts. Indoor concentrations of local traffic related fine
particles were modelled using an infiltration model [17].
Concentrations experienced while in traffic were pre-
dicted from EXPOLIS data [18] and scaled for the years
2002 and 2025 using predicted changes in tailpipe emis-
sions. Population exposures were estimated separately for
infants, adults, and elderly (0–1, 25–59, and 60–110
years, respectively). The exposure model [19-21] was
based on EXPOLIS-Helsinki study [22-24] that measured
exposure of adult population to various air pollutants in
the study area. Exposures of the infants and the elderly
were obtained by combining time activity data with the
measured concentration data in relevant microenviron-
ments. In the life-table model, the infant exposure was
extended for years 0–6 (below school age) and adult expo-
sure for the years 7–59 (table 1).
The exposure distributions were designed to represent
individual variations in the personal exposures. These dis-
tributions are likely to be wider than the uncertainty dis-
tributions for the age group averages, and therefore they
provide an upper limit estimate of the importance of
exposure uncertainty.
Four exposure scenarios (i-iv) were defined. (i) 'Current
with traffic' scenario assumed that the exposure to local
traffic related fine particles would remain at the year 2002
level. This is the base scenario used, and exposure uncer-
tainties were not included for this scenario. This is because
the combined effect of fine particle exposure and all other
causes of mortality are seen in the current mortality statis-
tics with very high precision and because the main aim is
to focus on uncertainties related to fine particles. There-
fore, the uncertainties in the current exposure to fine par-
ticle are propagated into scenarios ii and iii, which are
expressed in comparison to the baseline scenario.
(ii) 'Reduced traffic emissions' scenario assumed that the
exposure to fine particles due to local traffic would decline
linearly between the years 2002 and 2025 and would
remain constant thereafter. (iii) 'Current without traffic'
scenario assumed that the exposure to all local-traffic-
related fine particles was zero. Thus, the 'Current without
traffic' scenario can be used to predict loss of life-expect-
ancy due to traffic-related primary fine particles. (iv) The
'Additional exposure' scenario assumed a constant 10
µgm-3 exposure above the actual 2002 level after the year
2002 to the total population. The 'additional exposure'
scenario was used to compare the magnitude of the health
effects to those obtained in the other studies. The expo-
Table 2: The description of different scenarios. See Exposure scenarios sub-model -chapter for details.
Scenario
Current with traffic Reduced traffic 
emissions
Current without traffic Additional exposure
Follow-up period Years 2002–2112
Population Year 2002 Helsinki Metropolitan Area population
Primary PM2.5 health 
effects
Included in background 
mortality
Included in background 
mortality
Background mortality 
minus health effects of 
traffic related primary PM2.5 
exposure
Background mortality plus 
health effects of additional 
10 µgm-3 PM2.5 exposure
Primary PM2.5 exposure 
scenario
The actual 2002 exposure 
for 2002–2112
Actual 2002 exposure for 
2002, then a gradual 
decrease of local traffic 
exposure until 2025; 
constant thereafter
No traffic exposure 
between 2002–2112
Actual 2002 exposure plus 
10 µgm-3 for 2002–2112
Uncertainties in exposure 
taken into account
No Yes Yes NoEnvironmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
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sure scenarios and their properties are summarized in
table 2.
Exposure-response sub-model (βobs)
An exposure-response model was built to describe the
slope of the exposure-response function (βobs) of the
PM2.5 health effects in adults and in infants. Multiple
health outcomes have been detected in epidemiological
studies in relation to PM2.5, but in this study we consid-
ered only mortality due to long-term exposure. Slopes of
the exposure-response functions were estimated based on
the epidemiological studies conducted in the U.S [10,25].
Also the plausibility of association was included in the
model, defined as the probability that the observed expo-
sure-response association actually represents a causal
association (table 1). The plausibility of a health effect
was included in the exposure-response model using
author judgment based on a previous work [5]. Both plau-
sibility and exposure-response coefficient estimates and
assumptions are presented in Table 1.
There are many epidemiological studies on particulate
matter and infant mortality, and recently three reviews
have re-evaluated those studies [26-28]. All the reviewers
concluded that there is some evidence for some associa-
tion between PM levels and different mortality outcomes.
The reviewers also concluded that there were many weak-
nesses in these published studies, e.g. variations in diag-
nostics between the studies [27] and lack of controlling to
confounding factors (e.g. environmental tobacco smoke
and other air pollutants) [27]. It should also be noted that
most of the studies had used total suspended particles
(TSP) or PM10 as a measure of the particulate air pollu-
tion, although many epidemiological studies have
detected a stronger association between fine particles and
health effects [e.g. [29]]. We assumed that one of the larg-
est infant studies, the Woodruff et al. study [30], would
represent best the association between traffic-related fine
particles and total mortality, even though they used PM10
as a surrogate for particulate air pollution. The plausibility
that the observed exposure-response association actually
represents a causal association of the effect was assumed
to be 60% (table 1).
The slope of the exposure-response function for the ages
1–110 was estimated based on epidemiological studies.
There are several large epidemiological studies related to
adult chronic PM2.5 exposure (e.g. [10,31-33]). We calcu-
lated the concentration-response coefficient by drawing
values with equal probability from the result distributions
reported in the Dockery et al. 1993 and Pope et al. 2002
studies (table 1) [10,25]. These two studies were selected
because they had focused on overall fine particles expo-
sure (thus, not an any specific source), they measured all
the relevant health outcomes, and because we assume
them to be representative for primary fine particles
present the Helsinki Metropolitan Area. The equal proba-
bility was selected because we did not want to preferen-
tially emphasize either one of these studies. The
plausibility of the causal association for adult mortality
was assumed separately for three mortality outcomes. We
assumed that the probability for PM2.5 being the true
cause of the effects is 70%, 90% and 10% for cardiopul-
monary, lung cancer, and all other mortality, respectively.
The plausibility for cancer was highest because there are
known carcinogens in PM2.5 [34], while it is more debata-
ble what agent is responsible for the cardiovascular effects
in the air pollution mix.
The lag sub-model (L)
Lag was defined as the time for how long a given fine par-
ticle exposure (on a yearly basis) increases the incidence
of a health effect. The effect, when measured as relative
risk, was assumed to be distributed evenly between expo-
sure and the end of the lag period (see equation 1). The
lag assumptions were based on the environmental
tobacco smoke studies [35-38] and author judgment. For
the lung cancer, cardiopulmonary, and all other non-acci-
dental mortality, the lag was assumed to be 40, 15 and 1
years, respectively. The high lag assumptions were used to
avoid any underestimation of the importance of this vari-
able.
Monetary valuation
The monetary value of the years-of-life-lost and the rela-
tive importance of the uncertainties related to monetary
valuation were predicted to compare the relative impor-
tance of the monetary valuation on the health effect
uncertainties. The monetary valuation was based on the
value for a life-year lost (VOLY) estimates and discount
rates that were both adopted from The Clean Air for
Europe (CAFE) program.
The value of a life-year lost estimate was based on CAFE
program mean and median values (52000 and 120000
euros, respectively) [39]. The CAFE values were based
mainly on the NewExt study [40]. That study developed
an improved methodology for undertaking a monetary
valuation of mortality impacts from air pollution by using
the value-of-life-year-lost approach. We adopted the val-
ues used in the CAFE program and expressed the uncer-
tainty between the numbers with a uniform distribution
(table 1).
Benefits from reduced fine particle exposure occur in the
future. Discounting has been used in some fine particle
health effect studies [13,14] to express the present values
of these future benefits. The logic for this is that the bene-
fits are assumed to have lower utility, if they are post-
poned into the distant future. Also the public seems toEnvironmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
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discount future benefits [41]. In the CAFE program 4%
discount rate with 2% and 6% low and high estimates
were used [39]. We adopted these numbers and expressed
discount with uniform distribution ranging from 2% to
6% (table 1). Discounting was used only in monetary val-
uation.
Background hazard rates (Hb)
The background hazard rates (Hb) for cardiopulmonary,
lung cancer, other non-accidental, and accidental mortal-
ity were defined as the average mortality occurring over
the years 1988–2002 [42] (see additional file 1: Study
population.pdf for the population and mortality data).
Both mortality and population data were obtained for
ages 0–99. The hazard rates of the oldest age group (95–
99) were used for the years 100–110. Mortality statistics
had been coded using International Classification of Dis-
ease (ICD) codes version 9 (years 1988–1995) and 10
(years 1996–2002). ICD codes for cardiopulmonary, lung
cancer, and accidental mortality were 390–459, 1622–
1629, and 800–990, in version 9, respectively, and I00-
I99, F01, and V01-Y89 in version 10. Four fifths of mortal-
ity for the first age group (0-4-year-old) was assumed to
occur during the first year of life.
Impact indicators
Life-expectancy (LE) indicator was predicted in the life-
table model. The analyses were conducted for the Helsinki
metropolitan area population (year 2002) of approx. 1
million inhabitants. The population age structure, includ-
ing years lived before 2002, were taken into account in the
life-expectancy indicator. The population was sub-divided
into one-year age groups. The study population was fol-
lowed until the age of 110 years.
The effect of PM exposure on mortality rate (m) ratio is
typically predicted based on the following regression for-
mula:
ln(m) = α + β × E + ε (1)
where α is the background mortality coefficient, β is the
exposure-response coefficient and E is exposure (ε is a nui-
sance parameter). Since we are interested in the effects of
lag, we must assume that the observed β is actually a prod-
uct effect resulting from a cumulative exposure that
occurred before the observation. Thus,
where l is the time (in years) before the observation and
Hb is the background hazard rate (see additional file 1:
Study population.pdf for the population and mortality
data).
In this article we assume that the effects of a given expo-
sure are evenly distributed in time between the exposure
and the lag L (after which no effects occur), and that in the
cohort studies, the exposure was constant for at least L
years. In such a scenario, we can see that:
where RRobs is the observed risk ratio per unit exposure
of the exposure response function, and L is the maximum
lag in years. The mortality rates (m) were estimated for
each age group (ages 0–110) (i), year (years 2002–2112)
(y), mortality outcome (four different outcomes) (j) and
exposure scenarios (scenarios i-iv) (k). The calculated
mortality rates were then used to predict the survival of
the year 2002 population in the future.
The life-expectancy was predicted for the study popula-
tion by summing the years lived before 2002 and years
lived during the study time (years 2002–2112) and divid-
ing the sum with the year 2002 population size. The mon-
etary valuation was based on years-of-life-lost which
differed from the LE method by considering only the years
to be lived during the follow-up period and by estimating
the effects of fine particle exposure using monetary indica-
tor (euros). The differences between life-expectancy and
monetary valuation impact indicators are summarized in
table 3. See additional file 2 for the complete model.
Results
Factors identified as highly important included both
parameter and model uncertainties (Figure 1A–1C). The
plausibility of cardiopulmonary mortality (model uncer-
tainty) exhibited the highest importance in all scenarios.
The exposure-response coefficient of cardiopulmonary
mortality (parameter uncertainty) displayed high impor-
tance. Uncertainties related to lung cancer mortality and
other, non-accidental, mortality had low or negligible
mE H b E l l
L
l l
L =+ × = × × == ∑∑ exp( ( )) exp( ( )) αβ β 00
(2)
exp( ) β = RRobs L (3)
Table 3: The main properties of two impact indicators.
Impact indicator
Life-expectancy Monetary 
valuation
Follow-up period Years 2002–2112
Population Year 2002 Helsinki Metropolitan Area 
population
Exposure scenarios Yes Yes
Years lived before 2002 
taken into account
Yes No
Monetary valuation of 
life years
No Yes
Discounting No Yes
Sensitivity analyses Yes YesEnvironmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
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importance. The results of the sensitivity analyses were as
expected because of the high background mortality rates
for cardiopulmonary mortality. The results of the sensitiv-
ity analyses were double-checked with a modified value-
of-information analysis [2], in which the model result was
tested against the expectation value of the model. The
benefit of value of information analysis is that it is a deci-
sion analysis method that estimates the benefits of collect-
ing additional information and expressing it in a common
metric. Thus, it can be used to evaluate the importance of
a particular input variable (as in this case). The value of
information analysis confirmed the sensitivity analyses
results (data not shown). These results highlight the
importance of the cardiopulmonary mortality in compar-
ison to the other mortality outcomes.
The plausibility and exposure-response coefficients
related to infant mortality had minor importance in all
sensitivity analyses (figure 1A–1C). Thus, infant mortality
makes a low contribution to the population life-expect-
ancy although the individual loss of life is considerable.
However, the results would be expected to be different in
developing countries due to differences in the background
infant mortality rates and different cause-specific rates.
The lag vs. zero-lag input variable (model uncertainty)
seemed to be of minor importance (figure 1A–C). The a
priori hypothesis was that lag could be important since
the Finnish population is relatively old on average, and a
long lag could prevent the impact of lowering exposures
from benefiting for elderly subjects. It should be noted
that the lag assumptions used in this study were exceed-
ingly long, although a few intervention studies, especially
the coal ban in Dublin [31] and the Utah valley steel mill
strike [43], suggest that the major part of the effect is seen
within the first few years.
Discount and value of life-year-lost variables were very
important in comparison to the life-expectancy uncertain-
ties (figure 1B). The results showed how the uncertainties
related to placing a monetary valuation on the effects of
air pollution could have a more significant impact on the
results of the model than many input variables connected
to health effects evaluation. The effect of discount for the
different age groups is presented in Figure 2, showing
clearly how high discounts reduce the benefit to the
younger age groups if compared with those over 60 years.
On the other hand, the discounting did not affect the ben-
efits to people over 80 years of age.
The continued exposure to 10 µgm-3 fine particles lowered
the life-expectancy of the study population by 0.41 years
(mean; 90% confidence interval: 0.00 – 1.04). Previous
life-table models have predicted that the continued expo-
sure to 10 µgm-3 fine particles would lowers the life-
expectancy by anything between 0.42–1.5 years (table 4).
The magnitude of life-expectancy loss was lower in the
present study than in some of the previous life-table mod-
els. However, when the present model was run with a
birth cohort of imaginary 100000 children, without plau-
sibility estimations, and with the years 1988–1990 back-
ground hazard rates, the life-expectancy loss was 0.74
(mean, 90% CI 0.23 – 1.44) years (with 10 µgm-3 PM2.5
exposure). Even though the model uncertainties had sig-
nificant effects on model results, they were in agreement
with previous models results.
The exposure of the elderly is the most important uncer-
tainty of all the exposure variables (figure 1A–1B). This
Table 4: Comparison of the results of different life-table studies.
Study Life-expectancy effect per 
10 µgm-3 (years)
Effect per predicted 
exposure (years)
Predicted exposure (µgm-
3)
Relative risk estimates 
(mean) used in the study 
(per 10 µgm-3) (RR)
Brunekreef 1997 [7], high 1.51 1.51 10.0 1.10
Brunekreef 1997 [7], low 1.11 1.11 10.0 1.10
Nevalainen and Pekkanen
1998 [9], high
1.01 1.01 10.0 1.18a
Present study, high 0.74 0.74 10.0 See table 1
Mechler et al. 2002 [8] 0.64 1.36 21.1 1.06
Nevalainen and Pekkanen
1998 [9], low
0.60 0.60 10.0 1.20
Leksell and Rabl 2001 [13] 0.46 0.0006 1.0b 1.17
Present study, low 0.43 0.43 10.0 See table 1
Rabl 2003 [12] 0.42 0.38 15.0c 1.06
The results have been scaled to 10 µgm-3 PM2.5 exposure by assuming log-linearity between increased particle exposure and loss in life-expectancy. 
If two or more predictions were reported, the highest and lowest numbers were selected for the table. In the present study, the low prediction is 
the mean of the life-table model; the high prediction is the mean of the model without plausibility assumptions, with an imaginary birthcohort and 
with years 1988–1990 background hazard rates. See text for details. a) Only cardiopulmonary mortality. b) Not a life-time exposure but episode of 
one year increased exposure. c) Estimated for PM10. Converted to PM2.5 by using formula 1 µg PM10 = 0.6 µg PM2.5.Environmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
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Results from sensitivity analyses of the input variables Figure 1
Results from sensitivity analyses of the input variables. The bars show how each individual input variable correlated 
with the model output. The high correlations indicate that the input variable has a strong impact on the model output. The 
results are relative, such that removal of one uncertainty will affect the sensitivity of the other uncertainties. Sensitivity analysis 
was done by calculating absolute rank-order correlations between the input variables and the model output. A. Impact indica-
tor life-expectancy using the 'Current without traffic' scenario. B. Impact indicator monetary valuation using the difference 
between 'Current without traffic' and 'Reduced traffic emissions' scenarios. C. Impact indicator life-expectancy using the 'Addi-
tional exposure' scenario. ER = exposure-response.
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seems logical, as most of the health effects have been
observed in the older age groups. The use of individual
variation in exposure assessment overestimated the uncer-
tainty of the average population exposure and could
therefore lower the importance of other input variables.
However, when additional analyses were conducted with-
out exposure variability, it was noted that exposure did
not significantly affect the importance of the other input
variables (data not shown).
The life-expectancy predictions for the three exposure sce-
narios are presented in Figure 3. The difference between
the 'Current with traffic' and 'Current without traffic' sce-
narios was 0.04 years (mean, 90% CI -0.15 – 0.00), repre-
senting the life-expectancy loss in the study population
due to local traffic-related primary fine particles. In abso-
lute numbers (premature death) the local traffic was pre-
dicted to be responsible for 3.7, 27.2, and 0.2 lung cancer,
cardiopulmonary and other non-accidental mortality out-
comes in the year 2002, respectively. In the monetary val-
uation, the difference between the scenarios was 880
million euros/million inhabitants (when taking into
account discount and the monetary values from the year
2002 onward). The decline in fine particles exposure by
2025, as predicted here based on the HEAT -project,
improves the expected life-expectancy by 0.02 years. In
the monetary valuation, the benefits were predicted to be
390 million euros/million inhabitants (from year 2002
onward). These benefits materialize in the year 2002
cohort that was followed until the year 2112. The benefits
for the society are larger because the benefits to other peo-
ple in the future population are not included. The local
traffic-generated primary fine particles were shown to
have a significant effect on health status of the study pop-
ulation.
Discussion
In this study, we have made a comprehensive sensitivity
analysis of a fine particle life-table model. The uncertain-
ties relating to cardiopulmonary mortality have large
effects on life-table model results, whereas the uncertain-
ties attributable to lag and infant mortality have only
minor effects. The discount and value of a life-year varia-
bles had significant impact on the results when estimating
the monetary loss of the life years. The variability of expo-
sure had major effects on the life-table model results.
These results provided valuable information on the rela-
tive importance of different input variables in the life-
table model and make it possible to focus on those varia-
bles and uncertainties that have the highest impact on to
life-table model results and, thus, on decision making.
The sensitivity analyses showed that the life-table model
result is mainly attributable to the contribution of cardi-
opulmonary mortality. This was expected since the back-
ground cardiopulmonary mortality is higher than lung
cancer or non-accidental mortality and changes (and
Life-expectancy predictions for three different exposure sce- narios Figure 3
Life-expectancy predictions for three different expo-
sure scenarios. Predicted life-expectancy for three differ-
ent exposure scenarios (mean and 90% confidence intervals 
shown). The difference between scenarios 'Current without 
traffic' and 'Current with traffic' represents the current life-
expectancy loss in Helsinki Metropolitan Area due to local 
traffic emitted primary fine particles emissions. The 'Reduced 
traffic emissions' scenario describes the effect of a plausible 
emission reduction scenario for 2002–2025.
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uncertainties) related to the concentration-response func-
tion of cardiopulmonary mortality was expected to have a
major effect on the results. There are no significant differ-
ences in the magnitude of the effect between studies that
have separated the mortality outcomes (present study and
Nevalainen and Pekkanen study [9]) and studies that have
not (all others in table 4). Cardiopulmonary mortality is
declining in the developed countries, and this may affect
the results from fine particle life-table models if different
mortality outcomes are not separated in the analyses.
The plausibility was defined in this study as the probabil-
ity that the observed exposure-response association actu-
ally represents a causal association. The separation of
causal relationship and the exposure-response function
have also been under examination in the recent expert
elicitation study prepared by U.S. EPA [44]. The experts
were asked to give their best estimate for the likelihood
that there is a causal relationship between fine particles
and all-cause mortality. Their answers ranged from 100%
to 35%, though the majority of the experts thought that
the likelihood would be 95% or more [44]. In addition to
their best judgment, the expert also provided an estimate
of range. Our approach differs from the EPA study, so that
we separated the different mortality outcomes and used
only the best estimates. As an alternative approach, we
could also have tested the uncertainty around our best
guess for plausibility. However, it could also be argued
that plausibility is an inherently dichotomous variable
and the truth is always either zero or one.
When analyzing the importance of plausibility, we used
low plausibility estimates for different mortality out-
comes. It could be argued that this would overestimate the
current uncertainty on the plausibility of the association
between fine particles, especially for lung cancer, but
probably also for cardiovascular disease. With respect to
lung cancer, few experts have challenged the plausibility
for an association, but even for cardiovascular disease
there is more and more evidence to support the existence
of plausible mechanisms for an association [34,44,45].
However, the value 35%, represented in [44], shows that
the plausibility is still a major issue, although the current
evidence had convinces most of the experts [44]. The
plausibility assumptions have been estimated in our pre-
vious study [5] and the true uncertainty based on current
knowledge would probably show higher plausibility and
thus have lower importance in this analysis.
In the present study, various causes of death were assumed
to be statistically unrelated. The assumption means that
the individuals who benefit from lowering risks (by
removing the underlying cause of death) have a similar
probability to survive as the individuals that were not
threatened by the risk in the first place (in other words,
people who benefit do not have more competing causes
than the general population). It is likely that this assump-
tion is not completely valid as such. Mackenbach et al.
have investigated this question in a number of statistical
studies by comparing the magnitude of competing causes
in different underlying mortality outcomes from the
Dutch national cause-of-death register [46-48]. In their
latest analyses, they concluded that the prevalence of the
competing causes is high with respect to respiratory dis-
eases, about average with cardiovascular diseases, and low
with neoplasms [48]. This implies that patients with a
neoplasm have a lower risk of dying of other causes if they
survive the neoplasm. If applicable to this analysis, these
results could mean that the present life-table model may
over-predict the import of the cardiopulmonary mortality
while underestimating the import of the lung cancer.
The results from sensitivity analyses showed that both dis-
count rate and value of life-year had a large impact on life-
table model results when the results are presented using
monetary indicators. The monetary valuation was also
noted to be a major source of uncertainty in the CAFE
uncertainty analyses, when taking into account the full
chain of cost-benefit analysis [15]. The use of a monetary
valuation and discount in the health risk assessment is a
controversial issue. The driving force behind our analysis
was to compare the uncertainties related to health effect
variables with the corresponding uncertainties in mone-
tary variables. Our intention was not to commit on discus-
sion whether or not health effect should be valued in
monetary terms. The results suggested that uncertainties
related to monetary valuation are at least as important for
the results as the most important health evaluation varia-
bles.
The discount rate emphasizes the importance of the
health of the present population over the future genera-
tion; a principle that may be hard to accept. On the other
hand, the discount rate is widely used in the financial
analyses. According to economic theories, the discount
rate should be consistent with all future impacts evalu-
ated, whether health or economic. It has also been argued
that the discount rate can be used in health analyses to
weigh the impacts in relation to time and age. Pandey and
Nathwani [49] concluded that in cost-benefit analyses,
the discount rate evens out the disparity between young
and old ages in life-table models. A similar result was also
seen in this study when the result of the model were pre-
sented using a monetary indicator. The comparison of the
benefits of different age groups showed clearly that even a
low discount rate (2%) reduces the benefits to the
younger age groups and relatively emphasizes effects for
the middle-aged population (50 to 70 years old).Environmental Health 2007, 6:24 http://www.ehjournal.net/content/6/1/24
Page 11 of 13
(page number not for citation purposes)
The lag has been used in some previous life-table studies.
Leksell and Rabl [13] used a repair model to calculate the
decline in the relative risk (repair process) after a decline
in the exposure to fine particles. That model was based on
the time constant, which they measured from tobacco
smoking studies. Röösli et al. [50] adopted the Leksell and
Rabl model, but they used air pollution intervention stud-
ies to calculate a time constant. Both models measured the
association between fine particles and total non-acciden-
tal mortality. Although the authors estimated time con-
stants based on different studies, they both concluded that
it had little or no effect on life-table model results [13,50].
A similar result was seen in this study, although both the
lag sub-model and the lag assumptions used were differ
than those in the previous studies. The lag sub-model
used in this study assumed that the adverse effect of fine
particles would grow gradually while other models have
used delay functions. Therefore, the results of the present
study and the results from these other life-table models
are not fully comparable. However, taken together, it
could be concluded that lag is not an important input var-
iable for the fine particle life-table models and therefore it
could be ignored in future analyses.
Local traffic-related fine particles were shown to have a
notable effect on study population. However, this was
only a small part of the total exposure as the difference
between PM2.5 exposure scenarios were about or less than
0.5 µgm-3 while the total exposure in the study area is
about 10 µgm-3 [24]. The health effects of local traffic-
related particles were also addressed only for the local
population and thus the total health effects would have
been larger had the dispersion of pollutants outside the
study area been taken into account. Three of four exposure
scenarios were based on the HEAT-project that evaluated
traffic flows, air pollution emissions from traffic, resulting
ambient air concentrations and exposures, and health
effects in the study area. The scenarios took account of the
land use policy, changes in traffic flows and emissions and
the location and the time activity of the population. The
comparison of the exposure scenarios showed that with
the current policy, about half of the primary fine particles
effects due to local traffic can be avoided within twenty
years. The results show that the current actions are head-
ing in the right direction. However, more rapid actions
could be implemented, as the current transport system
plan is mostly focussed on road construction and public
transport subsidies and less on emission control, traffic
demand, or prevention of infiltration of outdoor particles
into buildings [51].
Conclusion
The uncertainties of a life-table model for estimation of
population health risks caused by local primary traffic
particles were investigated in detail using a sensitivity
analysis approach. The main results were: (i) uncertainties
in several input variables as well as in the model structure
were noted to have large effects on the model results. (ii)
The uncertainty in the plausibility of the cardiopulmonary
mortality, the exposure-response coefficient for cardiopul-
monary mortality, and PM2.5 exposure in the elderly pop-
ulation were major sources of uncertainty, whereas (iii)
uncertainty in the variables lag vs. zero-lag, exposure-
response coefficient for total mortality of infants, plausi-
bility of infant mortality effects, and other non-accidental
mortality were not major sources of uncertainty. The dis-
count and value of a life-year variables did have a signifi-
cant impact on the results when comparing the results of
two different exposure scenarios. The estimates used for
cardiopulmonary PM coefficient, plausibility, and PM2.5
exposure warrant updated estimates based on the current
scientific evidence. The discount rate is more of a political
issue, but this analysis showed that it is important to be
explicit about this issue. In contrast, complicated lag struc-
tures can be omitted without this having any major
impact on the results. The fine particle emissions attribut-
able to local traffic were shown to cause significant life-
expectancy loss in the Helsinki metropolitan area popula-
tion.
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